Viyash Scientific (VIYASH)
STALWARTFairStock Score: 2/100 — RISKY
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 1/2 · Dividend: 0/1
Key Financials
| Current Price | ₹211.76 |
| Market Cap | ₹9,303.45 Cr |
| P/E Ratio | 72.82 |
| ROCE | 8.47% |
| ROE | 0.96% |
| Dividend Yield | 0% |
| Profit Growth | 6.2% |
| Debt/Equity | 0.55 |
| Sales Growth | 10.9% |
| Promoter Holding | 61.41% |
| 52-Week Range | ₹178.13 — ₹277.05 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹25.3 |
Viyash Scientific trades with a P/E ratio of 72.82, ROCE of 8.47%, ROE of 0.96%, profit growth of 6.2%, debt-to-equity of 0.55. The FairStock Score of 2/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer